Aspen Neuroscience

Personalized medicine begins with you

San Diego, United States · Founded 2018 · $339.0M raised

Employees
51–200
Founded
2018
Business Model
B2B
Total Funding
$339.0M
Last Round
$115.0M Series CNov 2025
Rounds
4

About

Aspen Neuroscience is a clinical-stage biotech developing ANPD001, the world's first autologous iPSC-derived neuron replacement therapy for Parkinson's disease. Using a patient's own skin cells reprogrammed into dopamine-producing neurons, the treatment eliminates immunosuppression requirements and is currently in Phase 1/2a clinical trials.

Summary

Aspen Neuroscience is a Biotech company based in San Diego, United States, founded in 2018. It has raised $339.0M in total across 4 rounds, most recently a $115.0M Series C round in Nov 2025. Investors include ARCH Venture Partners, OrbiMed and Revelation Partners.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series CSeries CNov 2025
$115.0M

Sign up to see all 4 rounds

Seed through Series C — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aspen Neuroscience on Indexed.vc
<a href="https://indexed.vc/companies/aspen-neuroscience"><img src="https://indexed.vc/api/badge/company/aspen-neuroscience" alt="Aspen Neuroscience on Indexed.vc" width="260" height="76" /></a>